Home Exercise And Resiliency Training (Heart) Club
Launched by UNIVERSITY OF MICHIGAN · Sep 13, 2022
Trial Information
Current as of November 08, 2025
Recruiting
Keywords
ClinConnect Summary
The "Home Exercise And Resiliency Training (Heart) Club" study is looking at how a structured exercise program, delivered through telemedicine (meaning you can participate from home), can help people with Fontan heart physiology. This research aims to see if this program can improve physical fitness and reduce frailty, which means feeling weak or less capable. The study also wants to find out if this type of exercise can help with liver issues related to Fontan physiology and whether it makes it easier for people from different backgrounds to access exercise training.
To participate, you need to be 19 years or older and have Fontan physiology. However, some individuals may not qualify, such as those who are significantly shorter than 130 cm, pregnant, or have certain serious heart conditions. If you join the study, you can expect to engage in a home-based exercise routine with guidance, helping you to get stronger and healthier. Overall, this trial is important because it aims to find new ways to support individuals with specific heart conditions in improving their health and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males and females with Fontan physiology
- • 19 years old at age of enrollment
- Exclusion Criteria:
- • Height less than 130 centimeter (cm)
- • Pregnancy or the plan to become pregnant during the study period
- • Current intravenous inotropic drugs
- • Severe ventricular dysfunction assessed qualitatively by clinical echocardiography within six months prior to enrollment
- • Severe valvar regurgitation, ventricular outflow obstruction, or aortic arch obstruction assessed by clinical echocardiography within six months prior to enrollment
- • History of arrhythmia with exercise (excluding isolated supraventricular or ventricular ectopy without symptoms)
- • Inability to complete exercise testing at baseline screening
- • Noncardiac medical, psychiatric, and/or social disorder that would prevent successful completion of planned study testing or would invalidate its results
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Jesse Hansen, MD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials